Novartis Investigative Site

Kitamoto, Saitama 364-8501

0 studies enrolling now · 2 studies all time

What they study most

Sarcopenia

Studies at this site

• Dose Range Finding Study of Bimagrumab in Sarcopenia — Completed
• A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study — Completed